Search Results

There are 39264 results for: content related to: Recombinant interferon-α 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B

  1. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha

    British Journal of Haematology

    Volume 78, Issue 2, June 1991, Pages: 210–216, P. v. Wussow, D. Jakschies, M. Freund, R. Hehlmann, F. Brockhaus, H. Hochkeppel, M. Horisberger and H. Deicher

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1991.tb04418.x

  2. Epitopes recognized by neutralizing therapy-induced human anti-interferon-α antibodies are localized within the N-terminal functional domain of recombinant interferon-α2

    European Journal of Immunology

    Volume 26, Issue 9, September 1996, Pages: 2155–2159, Klaus-Ulrich Nolte, Gero Günther and Peter von Wussow

    Version of Record online : 17 NOV 2005, DOI: 10.1002/eji.1830260929

  3. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera

    European Journal of Haematology

    Volume 60, Issue 5, May 1998, Pages: 273–277, P. Foa, P. Massaro, S. Caldiera, M L. LaTargia, A. Iurlo, C. Clerici, M. Fornier, F. Bertoni and A. T. Maiolo

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1998.tb01039.x

  4. Synthesis and expression of MHC class II molecules in the absence of attached invariant chains by recombinant interferon-γ-activated bone marrow-derived macrophages

    European Journal of Immunology

    Volume 17, Issue 9, 1987, Pages: 1235–1242, Franz-Josef Schneider, Beate Opel, Wolfgang Ballhausen, Wolfgang Henkes, Peter Steinlein and Konrad Reske

    Version of Record online : 17 NOV 2005, DOI: 10.1002/eji.1830170904

  5. Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-γ followed by a synthetic lipid-a subunit analogue (GLA-60)

    International Journal of Cancer

    Volume 51, Issue 4, 19 June 1992, Pages: 641–645, I. Saiki, K. Sato, Y. C. Yoo, J. Murata, Junya Yoneda, M. Kiso, A. Hasegawa and I. Azuma

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910510422

  6. Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha

    Journal of Medical Virology

    Volume 45, Issue 4, April 1995, Pages: 439–444, Margarita Pardo, Inmaculada Castillo, Sonia Navas and Dr. Vicente Carreño

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890450415

  7. Recombinant interferon-γ inhibits the mitogenic effect of platelet-derived growth factor at a level distal to the growth factor receptor

    Journal of Cellular Physiology

    Volume 134, Issue 3, March 1988, Pages: 396–404, M. Hosang

    Version of Record online : 4 FEB 2005, DOI: 10.1002/jcp.1041340310

  8. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages*

    European Journal of Immunology

    Volume 18, Issue 10, October 1988, Pages: 1587–1592, Jean-Claude Drapier, Juana Wietzerbin and John B. Hibbs Jr

    Version of Record online : 22 NOV 2005, DOI: 10.1002/eji.1830181018

  9. You have free access to this content
    Recombinant interferon-γ lacks activity against metastatic colorectal cancer but increases serum levels of ca 19-9


    Volume 63, Issue 10, 15 May 1989, Pages: 1998–2004, Michael J. O'Connell, Roy A. Ritts JR, Charles G. Moertel, Allan J. Schutt and Stephen A. Sherwin

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19890515)63:10<1998::AID-CNCR2820631022>3.0.CO;2-L

  10. You have free access to this content
    Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial


    Volume 71, Issue 5, 1 March 1993, Pages: 1828–1834, Otto Prümmer and Delta-P Study Group

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19930301)71:5<1828::AID-CNCR2820710518>3.0.CO;2-0

  11. You have free access to this content
    Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover


    Volume 28, Issue 1, July 1998, Pages: 245–252, Prof. med. Stefan Zeuzem, Jürgen M. Schmidt, Jung-hun Lee, Michael von Wagner, Gerlinde Teuber and W. Kurt Roth

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510280132

  12. The effect of interferon on experimental metastases in immunocompetent and immunodeficient mice

    International Journal of Cancer

    Volume 37, Issue 4, 15 April 1986, Pages: 563–568, P. Ramani, I. R. Hart and F. R. Balkwill

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910370415

  13. 5-fluorouracil and low-dose recombinant interferon-α-2a in patients with hormone-refractory adenocarcinoma of the prostate

    The Prostate

    Volume 35, Issue 1, 1 April 1998, Pages: 56–62, Nobuo Shinohara, Takayoshi Demura, Kin-ya Matsumura, Ken-ichi Toyoda, Akira Kashiwagi, Satoshi Nagamori, Hiroshi Ohmuro, Sei-ichirou Ohzono and Tomohiko Koyanagi

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-0045(19980401)35:1<56::AID-PROS8>3.0.CO;2-F

  14. Practical uses of the interferons in dermatology

    International Journal of Dermatology

    Volume 37, Issue 12, December 1998, Pages: 881–896, Daniel S. Hurd DO and Eugene T. Conte DO

    Version of Record online : 5 JAN 2002, DOI: 10.1046/j.1365-4362.1998.00466.x

  15. Intralesional Alpha Interferon Therapy in Papillary Superficial Transitional Cell Carcinoma of the Bladder A Pilot Study

    British Journal of Urology

    Volume 71, Issue 4, April 1993, Pages: 422–426, S. M. DI STASI, G. VIRGILI, G. VESPASIANI, M. PORENA and F. MICALI

    Version of Record online : 26 NOV 2008, DOI: 10.1111/j.1464-410X.1993.tb15985.x

  16. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: Clinical responsiveness to recombinant ifn-α correlates with the degree of receptor down-regulation

    International Journal of Cancer

    Volume 43, Issue 2, 15 February 1989, Pages: 235–240, H. H. Bartsch, K. Pfizenmaier, A. Hanusch, P. Scheurich, U. Ücer and G. A. Nagel

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910430211

  17. Interferon-γ and Interleukin-4 down-regulate soluble CD14 release in human monocytes and macrophages

    Journal of Leukocyte Biology

    Volume 52, Issue 3, September 1992, Pages: 323–330, Regine Landmann, Ada E. Fisscher and Jean-Paul Obrecht

    Version of Record online : 1 SEP 1992, DOI: 10.1002/jlb.52.3.323

  18. Synergistic antiproliferative effects of glucocorticoids and interferon-α on some lymphoid cell lines

    Journal of Cellular Physiology

    Volume 134, Issue 1, January 1988, Pages: 85–92, Keith R. F. Elliott, Gerald L. Princler, Walter J. Urba and Connie R. Faltynek

    Version of Record online : 4 FEB 2005, DOI: 10.1002/jcp.1041340110

  19. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon


    Volume 7, Issue 6, December 1987, Pages: 325–332, Vicente Carreño, Juan C. Porres, Ignacio Mora, Javier Bartolomé, Caridad Bas, Julia Gutiez, José Cortés and Carlos Hernández Guio

    Version of Record online : 10 DEC 2008, DOI: 10.1111/j.1600-0676.1987.tb00363.x

  20. Characterization of the Induction of Persistent I-A Expression by Macrophages From Bcgr Mice

    Journal of Leukocyte Biology

    Volume 49, Issue 3, March 1991, Pages: 289–293, Mary Faris and Bruce S. Zwilling

    Version of Record online : 1 MAR 1991, DOI: 10.1002/jlb.49.3.289